Laura E Niklason sold $2.4M of Humacyte (HUMA)

Executed Sep 9 2024, disclosed Sep 11 2024, 2 days later.

Value, as filed

$2.4M

446,378 sh across 2 lots

Executed

Sep 9 2024

the trade date, as filed

Disclosed

Sep 11 2024

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Laura E Niklason President, CEO and Director profile →

Laura E Niklason (President, CEO and Director) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in Humacyte, Inc. (HUMA). The largest single filing was $6.6M of HUMA (1,500,000 sh across 3 lots, as filed), executed Nov 18 2024.

The name

HUMA

Humacyte, Inc. HUMA · Healthcare · 6 filings in 24 months ticker →

Healthcare · Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Laura E Niklason in HUMA

HUMASALE Humacyte, Inc. $3.7M
2,241,045 sh across 3 lots
Exec Aug 18 2025
Filed Aug 20 2025 · 5:30 PM ET HUMASALE Humacyte, Inc. $6.6M
1,500,000 sh across 3 lots
Exec Nov 18 2024
Filed Nov 20 2024 · 5:30 PM ET